X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (753) 753
Publication (69) 69
Book Chapter (15) 15
Book Review (13) 13
Book / eBook (5) 5
Dissertation (3) 3
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (491) 491
male (304) 304
index medicus (282) 282
cholesterol-lowering drugs (206) 206
female (202) 202
middle aged (186) 186
statins (171) 171
cholesterol-lowering therapy (158) 158
animals (156) 156
pharmacology & pharmacy (150) 150
cardiac & cardiovascular systems (148) 148
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (145) 145
aged (142) 142
cholesterol (134) 134
hypercholesterolemia (122) 122
atherosclerosis (114) 114
risk factors (111) 111
adult (108) 108
anticholesteremic agents - therapeutic use (102) 102
hypercholesterolemia - drug therapy (102) 102
cholesterol, ldl - blood (101) 101
coronary-heart-disease (97) 97
treatment outcome (94) 94
cholesterol - blood (93) 93
peripheral vascular disease (83) 83
simvastatin (80) 80
risk (76) 76
prevention (75) 75
lipids (74) 74
pravastatin (67) 67
anticholesteremic agents - pharmacology (64) 64
cholesterol lowering (64) 64
myocardial-infarction (62) 62
cardiovascular-disease (61) 61
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (60) 60
nutrition & dietetics (58) 58
biochemistry & molecular biology (57) 57
atorvastatin (56) 56
low-density-lipoprotein (55) 55
serum-cholesterol (55) 55
rats (54) 54
hypercholesterolemia - blood (53) 53
coronary-artery-disease (52) 52
research (52) 52
cardiovascular disease (51) 51
coronary heart disease (51) 51
double-blind method (50) 50
diet (49) 49
endothelium, vascular - drug effects (47) 47
health aspects (47) 47
lipids - blood (47) 47
analysis (46) 46
mortality (46) 46
cardiovascular diseases - prevention & control (45) 45
heart-disease (45) 45
anticholesteremic agents (44) 44
c-reactive protein (44) 44
cholesterol, hdl - blood (44) 44
endothelium (44) 44
low density lipoproteins (44) 44
medicine, general & internal (44) 44
prostate cancer (43) 43
care and treatment (42) 42
therapy (42) 42
article (41) 41
ezetimibe (41) 41
lovastatin (41) 41
risk-factors (41) 41
anticholesteremic agents - administration & dosage (40) 40
cardiovascular (40) 40
drug therapy (40) 40
efficacy (40) 40
nitric-oxide synthase (40) 40
statin (40) 40
oncology (39) 39
safety (39) 39
cardiovascular diseases (38) 38
drug therapy, combination (38) 38
metaanalysis (38) 38
lipoproteins (37) 37
atorvastatin calcium (36) 36
dose-response relationship, drug (36) 36
endothelium, vascular - physiopathology (36) 36
hmg-coa reductase (36) 36
metabolism (36) 36
cholesterol-lowering foods (35) 35
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (35) 35
medicine, research & experimental (35) 35
randomized controlled trials as topic (35) 35
triglycerides - blood (35) 35
cholesterol-lowering treatment (34) 34
familial hypercholesterolemia (34) 34
hypolipidemic agents - therapeutic use (34) 34
cholesterol - metabolism (33) 33
coenzyme-a reductase (33) 33
disease (33) 33
time factors (33) 33
coronary artery disease (32) 32
risk assessment (32) 32
endothelial function (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (744) 744
French (9) 9
German (6) 6
Japanese (5) 5
Spanish (5) 5
Russian (3) 3
Korean (2) 2
Chinese (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, ISBN 9780195323573, xvii, 201
Book
2011, 1st ed., ISBN 9780385535137, 385
Law firm partners Oscar Finley and Wally Figg see a chance for huge financial gain when they learn of a pending class action lawsuit against the makers of... 
Drugs | Class actions (Civil procedure) | Legal stories | Chicago (Ill.) | Anticholesteremic agents | Products liability
Book
2007, 1st ed., ISBN 9780123739797, xx, 227 p., [3] p. of plates
Today, in the era of the statins (cholesterol lowering drugs), there is no longer any doubt about the value of lowering blood cholesterol levels. This book... 
Hypercholesteremia | Clinical & internal medicine | Hypercholesterolemia - drug therapy
Book
Circulation, ISSN 0009-7322, 04/2007, Volume 115, Issue 16, pp. 2128 - 2135
Background - As medication spending grows, Medicare Part D will need to adapt its coverage policies according to emerging evidence from a variety of insurance... 
Drugs | Health care costs | Economics, pharmaceutical | Statins | CHOLESTEROL-LOWERING THERAPY | economics, pharmaceutical | CARDIAC & CARDIOVASCULAR SYSTEMS | MEDICATIONS | drugs | PERSISTENCE | PROTON PUMP INHIBITORS | health care costs | IMPACT | OLDER PATIENTS | statins | ECONOMIC CONSEQUENCES | DISEASE | PERIPHERAL VASCULAR DISEASE | PRAVASTATIN | HEALTH | Drug Costs | Insurance Coverage - economics | Follow-Up Studies | Humans | National Health Programs - economics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | Male | British Columbia | Cost Sharing - economics | Insurance Coverage - statistics & numerical data | Deductibles and Coinsurance - statistics & numerical data | Insurance, Pharmaceutical Services - classification | Patient Compliance - statistics & numerical data | Insurance, Pharmaceutical Services - statistics & numerical data | Myocardial Infarction - drug therapy | Deductibles and Coinsurance - economics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged, 80 and over | Female | Aged | Cost Sharing - statistics & numerical data | National Health Programs - statistics & numerical data | Cohort Studies | Insurance, Pharmaceutical Services - economics | Economic aspects | Influence | Dosage and administration | Research | Drug therapy | Prescription drug plans | Patient compliance | Heart attack
Journal Article
Oncology Reports, ISSN 1021-335X, 01/2017, Volume 37, Issue 2, pp. 953 - 960
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2012, Volume 32, Issue 3, pp. 669 - 676
OBJECTIVE—Nicotinic acid (NA) treatment has been associated with benefits in atherosclerosis that are usually attributed to effects on plasma lipoproteins. The... 
atherosclerosis | macrophages | vascular biology | receptors | cholesterol-lowering drugs | LONG-TERM | INTEGRIN VLA-4 | ACTIVATION | DENDRITIC CELLS | KAPPA-B | FOAM CELLS | ENDOTHELIAL-CELLS | PERIPHERAL VASCULAR DISEASE | MICE | HEMATOLOGY | EXTENDED-RELEASE NIACIN | Tumor Necrosis Factor-alpha - metabolism | Phosphorylation | Integrin alpha4beta1 - metabolism | Toll-Like Receptor 2 - agonists | Human Umbilical Vein Endothelial Cells - metabolism | Receptors, G-Protein-Coupled - metabolism | Humans | Human Umbilical Vein Endothelial Cells - immunology | Monocytes - metabolism | Monocytes - immunology | Niacin - pharmacology | Receptors, Prostaglandin - metabolism | Receptors, Immunologic - antagonists & inhibitors | Inflammation - metabolism | Transfection | Chemotaxis, Leukocyte - drug effects | I-kappa B Kinase - metabolism | RNA Interference | Inflammation Mediators - metabolism | Toll-Like Receptor 4 - agonists | Chemokine CCL2 - metabolism | Receptors, G-Protein-Coupled - drug effects | Interleukin-6 - metabolism | Receptors, Prostaglandin - antagonists & inhibitors | Receptors, Nicotinic - drug effects | Receptors, Nicotinic - metabolism | Human Umbilical Vein Endothelial Cells - drug effects | Cyclooxygenase 2 Inhibitors - pharmacology | Anti-Inflammatory Agents - pharmacology | Cells, Cultured | Inflammation - immunology | Toll-Like Receptor 2 - metabolism | Cell Adhesion - drug effects | Toll-Like Receptor 4 - metabolism | Monocytes - drug effects | Transcription Factor RelA - metabolism | Lipopolysaccharides - pharmacology | Inflammation - genetics | Receptors, G-Protein-Coupled - genetics | Pyrazines - pharmacology | Vascular Cell Adhesion Molecule-1 - metabolism | Receptors, Nicotinic - genetics | Receptors, Immunologic - metabolism
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, ISSN 1079-5642, 05/2003, Volume 23, Issue 5, pp. 729 - 736
ABSTRACT—The vascular endothelium is a dynamic endocrine organ that regulates contractile, secretory, and mitogenic activities in the vessel wall and... 
3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitor | Protein kinase Akt | Cholesterol | Atherosclerosis | Endothelium | atherosclerosis | protein kinase Akt | C-REACTIVE PROTEIN | PROGENITOR CELLS | endothelium | COA REDUCTASE INHIBITOR | CHOLESTEROL-LOWERING THERAPY | NITRIC-OXIDE SYNTHASE | ACUTE CORONARY SYNDROMES | SUPEROXIDE ANION PRODUCTION | VASCULAR SMOOTH-MUSCLE | cholesterol | PERIPHERAL VASCULAR DISEASE | LEUKOCYTE ADHESION | HEMATOLOGY | ARTERY DISEASE | Arteriosclerosis - etiology | Fibrinolysis - drug effects | Protein Prenylation - drug effects | Cholesterol - blood | Humans | Arteriosclerosis - physiopathology | Endothelium, Vascular - drug effects | Cell Adhesion - drug effects | Hypercholesterolemia - drug therapy | Vasoconstriction - drug effects | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Endothelium, Vascular - physiology | Naphthalenes - pharmacology | Arteriosclerosis - prevention & control | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Protein Processing, Post-Translational - drug effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypercholesterolemia - complications | Oxidative Stress - drug effects | Nitric Oxide - metabolism | Anticholesteremic Agents - pharmacology | Naphthalenes - therapeutic use
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 07/2018, Volume 12, Issue 4, pp. 857 - 862
Time to benefit (TTB) in clinical trials of cholesterol-lowering drugs is important because it may provide a clue as to the potential mechanism of action of... 
Clinical trials | Cholesterol lowering | Time to benefit | Statins | HIGH-DOSE ATORVASTATIN | MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | RANDOMIZED CONTROLLED-TRIAL | SECONDARY PREVENTION | DENSITY-LIPOPROTEIN CHOLESTEROL | PRIMARY-PREVENTION | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | ACTIVE METABOLITE
Journal Article